Kristofer Andréasson

1.6k total citations · 1 hit paper
40 papers, 990 citations indexed

About

Kristofer Andréasson is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Kristofer Andréasson has authored 40 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Kristofer Andréasson's work include Systemic Sclerosis and Related Diseases (26 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Kristofer Andréasson is often cited by papers focused on Systemic Sclerosis and Related Diseases (26 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Kristofer Andréasson collaborates with scholars based in Sweden, United States and Denmark. Kristofer Andréasson's co-authors include Elizabeth R. Volkmann, Vanessa Smith, Roger Hesselstrand, Jan Marsal, Tore Saxne, Bodil Ohlsson, Thomas Mandl, Göran Jönsson, A Scheja and Anita Persson and has published in prestigious journals such as The Lancet, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Kristofer Andréasson

37 papers receiving 980 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic sclerosis

2022 276 citations Elizabeth R. Volkmann, Kristofer Andréasson et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristofer Andréasson Sweden	15	509	277	252	215	202	40	990
Amelia Chiara Trombetta Italy	18	495 1.0×	145 0.5×	226 0.9×	253 1.2×	412 2.0×	32	1.1k
Nicole Fett United States	17	573 1.1×	90 0.3×	129 0.5×	379 1.8×	119 0.6×	62	1.2k
B Kalis France	19	393 0.8×	209 0.8×	156 0.6×	420 2.0×	295 1.5×	81	1.2k
D. Antoniades Greece	19	318 0.6×	155 0.6×	122 0.5×	121 0.6×	88 0.4×	60	1.4k
Marta Carlesimo Italy	18	161 0.3×	133 0.5×	90 0.4×	419 1.9×	128 0.6×	79	1.0k
Simona Fisogni Italy	20	147 0.3×	156 0.6×	331 1.3×	288 1.3×	144 0.7×	56	1.5k
Andrew G. Franks United States	20	431 0.8×	114 0.4×	63 0.3×	378 1.8×	330 1.6×	99	1.2k
Jordi Peyrı́ Spain	22	347 0.7×	102 0.4×	219 0.9×	618 2.9×	249 1.2×	59	1.3k
Hiroshi Ohnishi Japan	21	193 0.4×	180 0.6×	714 2.8×	74 0.3×	414 2.0×	81	1.6k
Kee‐Chan Moon South Korea	19	256 0.5×	63 0.2×	134 0.5×	592 2.8×	115 0.6×	133	1.3k

Countries citing papers authored by Kristofer Andréasson

Since Specialization

Citations

This map shows the geographic impact of Kristofer Andréasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristofer Andréasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristofer Andréasson more than expected).

Fields of papers citing papers by Kristofer Andréasson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristofer Andréasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristofer Andréasson. The network helps show where Kristofer Andréasson may publish in the future.

Co-authorship network of co-authors of Kristofer Andréasson

This figure shows the co-authorship network connecting the top 25 collaborators of Kristofer Andréasson. A scholar is included among the top collaborators of Kristofer Andréasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristofer Andréasson. Kristofer Andréasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andréasson, Kristofer, Arissa Young, Swapna Joshi, et al.. (2025). International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease. Arthritis Care & Research. 78(3). 352–361.

McGuigan, Fiona E., et al.. (2024). Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women—a case–control study. Lara D. Veeken. 64(5). 2783–2791. 2 indexed citations

Andréasson, Kristofer, et al.. (2023). Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome. Seminars in Arthritis and Rheumatism. 60. 152185–152185. 9 indexed citations

Andréasson, Kristofer, et al.. (2023). Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?. Nature Reviews Rheumatology. 19(10). 675–675.

Wildt, Marie, et al.. (2023). Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. Lara D. Veeken. 63(2). 385–391. 3 indexed citations

Nielsen, Christel, Kristofer Andréasson, Håkan Olsson, Malin Engfeldt, & Anna Jöud. (2023). Cohort profile: The Swedish Tattoo and Body Modifications Cohort (TABOO). BMJ Open. 13(5). e069664–e069664. 9 indexed citations

Sohrabian, Azita, Elizabeth R. Volkmann, Marie Wildt, et al.. (2023). Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study. Arthritis Research & Therapy. 25(1). 162–162. 12 indexed citations

Wallman, Johan K., et al.. (2022). Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis. Rheumatology International. 43(5). 961–967. 5 indexed citations

Volkmann, Elizabeth R., Kristofer Andréasson, & Vanessa Smith. (2022). Systemic sclerosis. The Lancet. 401(10373). 304–318. 276 indexed citations breakdown →

10.

Andréasson, Kristofer, Göran Rådegran, Hans Brunnström, Dirk M. Wuttge, & Roger Hesselstrand. (2019). Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ. Lara D. Veeken. 59(5). 1177–1179. 2 indexed citations

11.

Božović, Gracijela, et al.. (2019). Exocrine pancreatic function is preserved in systemic sclerosis. Arthritis Research & Therapy. 21(1). 52–52.

12.

Andréasson, Kristofer, Göran Jönsson, Roger Hesselstrand, & Hans Norrgren. (2019). Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication. World Journal of Hepatology. 11(3). 330–334. 2 indexed citations

13.

Mandl, Thomas, Jan Marsal, Peter Olsson, Bodil Ohlsson, & Kristofer Andréasson. (2017). Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity. Arthritis Research & Therapy. 19(1). 237–237. 94 indexed citations

14.

Andréasson, Kristofer, Bodil Ohlsson, & Thomas Mandl. (2016). Elevated levels of faecal calprotectin in primary Sjögren’s syndrome is common and associated with concomitant organic gastrointestinal disease. Arthritis Research & Therapy. 18(1). 9–9. 14 indexed citations

15.

Hesselstrand, Roger, et al.. (2015). High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study. Arthritis Research & Therapy. 17(1). 329–329. 28 indexed citations

16.

Andréasson, Kristofer, et al.. (2014). Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometry. Scandinavian Journal of Rheumatology. 43(5). 391–397. 7 indexed citations

17.

Andréasson, Kristofer, et al.. (2013). Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria. Annals of the Rheumatic Diseases. 73(10). 1788–1792. 69 indexed citations

18.

Hesselstrand, Roger, Marie Wildt, Gracijela Božović, et al.. (2013). Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respiratory Medicine. 107(7). 1079–1086. 53 indexed citations

19.

Agarwal, Pallavi, Jan-Niklas Schulz, Katrin Blumbach, et al.. (2013). Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biology. 32(6). 325–331. 56 indexed citations

20.

Rydell‐Törmänen, Kristina, Kristofer Andréasson, Roger Hesselstrand, et al.. (2012). Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. Laboratory Investigation. 92(6). 917–925. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact